Proactively evaluate Fresenius Kabi AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
|Event Date||Event Type||Company Name||Ticker Symbol||Drug Name||Therapy Area||Indication||Source Type|
|13 Apr 2022||GDCTXXXX||Lorem||Lorem||Lorem||XXXX||Planned||Lorem|
|01 Dec 2021||Phase IV Trial Initiation||Fresenius Kabi AG||-||SMOFlipid||Gastrointestinal||Liver Diseases||Regulatory Website|
|01 Jul 2020||Phase II Trial Initiation||Fresenius Kabi AG; Stellenbosch University||-||Aminoven||Musculoskeletal Disorders||Unspecified Musculoskeletal Disorders||Clinical Trial Registry|
|17 Mar 2020||Phase I Trial Completion||Fresenius Kabi SwissBioSim GmbH; PRA Health Sciences Inc||-||adalimumab biosimilar||Dermatology; Gastrointestinal; Immunology; Musculoskeletal Disorders; Ophthalmology||Ankylosing Spondylitis (Bekhterev's Disease); Crohn's Disease (Regional Enteritis); Hidradenitis Suppurativa; Plaque Psoriasis (Psoriasis Vulgaris); Polyarticular Juvenile Idiopathic Arthritis (PJIA); Psoriatic Arthritis; Rheumatoid Arthritis; Ulcerative Colitis; Uveitis||Clinical Trial Registry|
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer